PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Triamcinolone acetonide - Allergic rhinitis
PAD Profile : Triamcinolone acetonide - Allergic rhinitis
Keywords :
Hay fever, hayfever, allergy, seasonal allergic rhinitis, pollen allergy, corticosteroids, corticosteroid injections
Brand Names Include :
Kenalog, Nasacort
Traffic Light Status
Status 1 of 2.
Status :
Non Formulary
Formulations :
- Injection
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 2.
Status :
Green (see narrative)
Important
Formulations :
- Nasal spray
Important Information :
Beclometasone (200 dose container) is the preferred intranasal steroid for allergic rhinitis. Triamcinolone is considered to be a 3rd / 4th line agent.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Fluticasone furoate
- Cetirizine hydrochloride
- Loratadine
- Beclometasone dipropionate
- Azelastine hydrochloride
- Desloratadine
- Levocetirizine
- Budesonide
- Mometasone furoate
- Ipratropium bromide
- Bilastine
- Mizolastine
- Acrivastine
- Fexofenadine hydrochloride
- Rupatadine fumarate
- House dust mites allergen extract
- White Birch pollen allergen extract
- Mometasone furoate/olopatadine hydrochloride
- Chlorphenamine maleate
- Ketotifen fumarate
- Promethazine hydrochloride
- Fluticasone propionate (Nasal)
Other Indications
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
05 April 2023
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
Depot steroids should not be prescribed for hay fever. Evidence of safety is lacking, and there is a significant risk of prolonged side-effects (e.g. osteoporosis) which cannot be mitigated by withdrawal of the drug
05 April 2023
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
Triamcinolone nasal spray is considered to be a 3rd / 4th line agent for nasal allergic rhinitis - see local guidelines below.
Associated BNF Codes
06. Endocrine System
06.03.02. Glucocorticoid therapy